Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Yabao Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Yabao Pharmaceutical
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Announcement on Obtaining the Registration Certificate for Formula Foods for Special Medical Purposes
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Progress in Repurchased Company Shares Reaching 1% and Repurchase
- Report for Q3 2025
Later from Yabao Pharmaceutical
- Announcement on the Change of Signatory Certified Public Accountant and Quality Control Reviewer for the Audit Institution
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials of GLX002
- Announcement on Profit Distribution Plan for Q3 2025
- Announcement on Progress in the Sale of Subsidiary Equity and Completion of Industrial and Commercial Registration Change
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Yabao Pharmaceutical into a list and get an email when it puts out news.
Follow Yabao Pharmaceutical